Niagen Bioscience (NAGE) Assets Average (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Assets Average data on file, last reported at $110.4 million in Q1 2026.

• Assets Average for Q1 2026 came in at $110.4 million, up 47.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.4 million (up 47.54% YoY), and the FY2025 annual result was $87.3 million, up 41.74% from the prior year.
• Assets Average climbed to $110.4 million in Q1 2026 per NAGE's latest filing, from $102.3 million in the prior quarter.
• Over five years, Assets Average peaked at $110.4 million in Q1 2026 and troughed at $46.1 million in Q3 2022.
• A 5-year average of $65.4 million and a median of $54.5 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2025: Assets Average slipped 26.93% in 2022, then surged 71.55% in 2025.
• A 5-year view of Assets Average shows it stood at $49.9 million in 2022, then advanced by 8.75% to $54.2 million in 2023, then gained by 15.08% to $62.4 million in 2024, then soared by 63.9% to $102.3 million in 2025, then climbed by 7.92% to $110.4 million in 2026.
• Business Quant data shows NAGE's Assets Average at $110.4 million in Q1 2026, $102.3 million in Q4 2025, and $94.8 million in Q3 2025.